We first conducted genomic analyses of 489 human ovarian serous cystadenocarcinomas using the Cancer Genomics Atlas (TCGA), which revealed an inverse relationship between LRRC4 and PIK3R1 expression (Figure 4A). This evidence concerns the gene PIK3R1 and ovarian serous cystadenocarcinoma.